A Study to Demonstrate the Non-Inferiority of Influenza Vaccine Candidate, Compared With Fluarix Administered Intramuscularly in Elderly Aged 60 Years Old and Above.

Trial Profile

A Study to Demonstrate the Non-Inferiority of Influenza Vaccine Candidate, Compared With Fluarix Administered Intramuscularly in Elderly Aged 60 Years Old and Above.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2016

At a glance

  • Drugs GSK 1247446A (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 14 Nov 2011 Actual end date (Dec 2006) added as reported by ClinicalTrials.gov.
    • 27 Oct 2008 Trial end date changed from 1 Dec 2006 to 1 Jul 2006 as reported by ClinicalTrials.gov.
    • 14 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top